How Drug Price Reform Will Affect Specialty Pharmacy

Video

Doug Long, vice president of Industry Relations at IQVIA, discusses rebate reform surrounding Medicare Part D and Part B in an interview with Specialty Pharmacy Times.

Doug Long, vice president of Industry Relations at IQVIA, discusses rebate reform surrounding Medicare Part D and Part B in an interview with Specialty Pharmacy Times.

Transcript

It's unknown, because we were going to do rebate reform on Medicare Part D, but ultimately, they decided to go with reference pricing on Medicare Part B, which I think will have a big impact on Medicare Part B drugs. We'll see how that goes, the Senate just proposed some things that I haven't had a chance to look out. I know it's a top priority for President Trump to show progress on prescription drugs. The challenge is that there are $166 billion of rebates in the system. A lot of those go to the government, a lot of that goes to sponsors, and nobody wants to really give them up. So, we'll have to see on that one as well.

Related Videos
Image credit:  Gorodenkoff | stock.adobe.com
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Image Credit: © Анастасія Стягайло - stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.